--- title: "Marchex-B | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 11 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295709010.md" datetime: "2026-08-12T20:58:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295709010.md) - [en](https://longbridge.com/en/news/295709010.md) - [zh-HK](https://longbridge.com/zh-HK/news/295709010.md) generator: "portal-rs" --- # Marchex-B | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 11 M Revenue: As of FY2026 Q2, the actual value is USD 11 M, missing the estimate of USD 11.2 M. EPS: As of FY2026 Q2, the actual value is USD -0.01. EBIT: As of FY2026 Q2, the actual value is USD -297 K. ### Revenue Marchex, Inc. reported revenue of $11.0 million for the second quarter of 2026, a decrease from $11.7 million in the second quarter of 2025. For the six months ended June 30, 2026, revenue was $21.620 million, down from $23.058 million for the same period in 2025. ### Net Income (Loss) Marchex, Inc. reported a net loss of - $0.4 million for the second quarter of 2026, compared to a net income of $0.1 million in the second quarter of 2025. The net loss applicable to common stockholders for the six months ended June 30, 2026, was - $2.132 million, compared to - $1.897 million for the six months ended June 30, 2025. ### Adjusted EBITDA Adjusted EBITDA for the second quarter of 2026 was $0.7 million, an increase from $0.6 million in the second quarter of 2025. This figure includes $1.0 million of reorganization and acquisition-related costs, making Adjusted EBITDA before these costs $1.7 million. ### Adjusted Non-GAAP Income Per Share Adjusted non-GAAP income per share was $0.00 for the second quarter of 2026, down from $0.02 for the second quarter of 2025. ### Operating Expenses Total operating expenses for the second quarter of 2026 were $11,348 thousand, compared to $12,191 thousand in the second quarter of 2025. For the six months ended June 30, 2026, total operating expenses were $23,317 thousand, down from $25,464 thousand in the prior year period. - **Cost of revenue:** $4,404 thousand for Q2 2026 ($4,068 thousand for Q2 2025) and $8,602 thousand for the six months ended June 30, 2026 ($8,256 thousand for the six months ended June 30, 2025). - **Sales and marketing:** $2,298 thousand for Q2 2026 ($3,165 thousand for Q2 2025) and $5,556 thousand for the six months ended June 30, 2026 ($6,431 thousand for the six months ended June 30, 2025). - **Product development:** $1,991 thousand for Q2 2026 ($2,501 thousand for Q2 2025) and $4,399 thousand for the six months ended June 30, 2026 ($5,173 thousand for the six months ended June 30, 2025). - **General and administrative:** $2,655 thousand for Q2 2026 ($2,457 thousand for Q2 2025) and $4,760 thousand for the six months ended June 30, 2026 ($5,604 thousand for the six months ended June 30, 2025). ### Loss from Operations Loss from operations was - $346 thousand for the second quarter of 2026, compared to - $536 thousand for the second quarter of 2025. For the six months ended June 30, 2026, loss from operations was - $1,697 thousand, compared to - $2,406 thousand for the same period in 2025. ### Cash and Cash Equivalents Cash and cash equivalents were $8,151 thousand as of June 30, 2026, decreasing from $9,942 thousand as of December 31, 2025. ### Total Assets and Liabilities Total assets were $37,631 thousand as of June 30, 2026, down from $39,680 thousand as of December 31, 2025. Total liabilities were $8,600 thousand as of June 30, 2026, decreasing from $9,595 thousand as of December 31, 2025. ### Total Stockholders’ Equity Total stockholders’ equity was $29,031 thousand as of June 30, 2026, compared to $30,085 thousand as of December 31, 2025. ### Pro Forma Combined Marchex and Archenia Financial Highlights #### Pro Forma Combined Revenue For the first quarter of 2026, pro forma combined revenue was $14.4 million, and for the second quarter of 2026, it was $15.5 million. #### Pro Forma Combined Adjusted EBITDA Pro forma combined Adjusted EBITDA for the first quarter of 2026 was - $0.1 million, including $0.7 million of reorganization and acquisition-related costs, resulting in an Adjusted EBITDA of $0.6 million before these costs. For the second quarter of 2026, pro forma combined Adjusted EBITDA was $1.0 million, including $1.0 million of reorganization and acquisition-related costs, leading to an Adjusted EBITDA of $2.0 million before these costs. #### Pro Forma Combined Net Loss Pro forma combined net loss applicable to common stockholders was - $235 thousand for the three months ended June 30, 2026, and - $2,046 thousand for the six months ended June 30, 2026. #### Pro Forma Combined Loss from Operations Pro forma combined loss from operations was - $106 thousand for the three months ended June 30, 2026, and - $1,476 thousand for the six months ended June 30, 2026. ### Financial Outlook Marchex, Inc. anticipates pro forma combined revenue for the three months ending September 30, 2026, to be in the range of $16.0 million to $16.5 million. Pro forma combined Adjusted EBITDA, net of reorganization and acquisition costs, is expected to be between $2.3 million and $2.5 million for the same period. The company plans to provide its Fourth Quarter 2026 Financial Outlook and initial 2027 business outlook when it reports Third Quarter 2026 Financial results in early November 2026. ### Related Stocks - [MCHX.US](https://longbridge.com/en/quote/MCHX.US.md) ## Related News & Research - [Marchex Earnings Call: Archenia Deal Fuels Aggressive Outlook](https://longbridge.com/en/news/296715058.md) - [Marchex (MCHX) Receives a Buy from Northland Securities](https://longbridge.com/en/news/295810897.md) - [Skye Bio amends 8-K to set Aug. 24 effective date for reverse stock split](https://longbridge.com/en/news/296471274.md) - [Getty Realty amends 8-K to detail Eugene Shnayderman separation, including $300,000 cash payment](https://longbridge.com/en/news/296534890.md) - [Copart amends 8-K to disclose Jane Pocock president compensation package](https://longbridge.com/en/news/296397117.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**